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Mammalian iron metabolism is regulated systemi-
cally by the hormone hepcidin and cellularly by iron
regulatory proteins (IRPs) that orchestrate a post-
transcriptional regulatory network. Through ligand-
inducible genetic ablation of both IRPs in the gut
epithelium of adult mice, we demonstrate that IRP
deficiency impairs iron absorption and promotes
mucosal iron retention via a ferritin-mediated
‘‘mucosal block.’’ We show that IRP deficiency
does not interfere with intestinal sensing of body
iron loading and erythropoietic iron need, but rather
alters the basal expression of the iron-absorption
machinery. IRPs thus secure sufficient iron transport
across absorptive enterocytes by restricting the
ferritin ‘‘mucosal block’’ and define a basal set point
for iron absorption upon which IRP-independent
systemic regulatory inputs are overlaid.INTRODUCTION
In the absence of a regulated physiological mechanism for iron
excretion, iron absorption by the proximal intestine is a critical
determinant of body iron availability and loading in mammals
(Hentze et al., 2010; Knutson, 2010). After reduction by ferrire-
ductases such as duodenal cytochrome b (DCYTB, a.k.a.
CYBRD1), dietary nonheme iron is transported from the gut
lumen across the apical membrane of enterocytes via divalent
metal transporter 1 (DMT1, a.k.a. SLC11A2). Iron is then translo-
cated through the cell and exported into the circulation by the
basolateral efflux channel ferroportin (FPN, a.k.a. SLC40A1) in
conjunction with the multicopper ferroxidase hephaestin. Intes-
tinal iron absorption is subject to tight regulation: it increases
with body iron requirements and decreases when body iron
stores enlarge. Early studies have shown that a single bolus of
oral iron could inhibit the absorption of a test dose of radioiron
given only a few hours later (Hahn et al., 1943; Stewart et al.,
1950). The rapid development of this refractory state, referred
to as the ‘‘mucosal block,’’ supported the notion of local regula-844 Cell Reports 3, 844–857, March 28, 2013 ª2013 The Authorstion of iron absorption by the enterocyte, and more particularly
by its ferritin content (Granick, 1946).
The more recent discovery of hepcidin (a.k.a. HAMP), a poly-
peptidic humoral factor that signals body iron levels and ery-
throid requirements, has increasingly discounted the mucosal
block and recognized the hepatic hormone hepcidin as a major
way to control iron absorption. Hepcidin secretion by hepato-
cytes increases in response to iron loading and decreases
upon stimulation of erythropoiesis (Ganz and Nemeth, 2012).
The current view is that hepcidin inhibits the release of iron
from absorptive enterocytes (and iron-recycling macrophages)
into the circulation by binding to and promoting the internaliza-
tion and subsequent degradation of FPN (Nemeth et al., 2004).
Iron is then stored in ferritin and lost when mucosal cells exfo-
liate. The importance of the hepcidin/FPN regulatory axis for
the regulation of systemic iron levels is highlighted by the fact
that most forms of hereditary hemochromatosis are caused by
mutations that target hepcidin or FPN themselves or the path-
ways that control hepcidin expression (Brissot et al., 2011).
Iron absorption in mice with intestinal deficiency for, respec-
tively, the iron-sequestering protein ferritin H (Vanoaica et al.,
2010) and the HIF2a (hypoxia inducible factor 2a, a.k.a.
EPAS1) transcription factor (Mastrogiannaki et al., 2009; Shah
et al., 2009) is, however, abnormal in spite of adequate hepcidin
regulation, indicating that iron absorption is also regulated within
mucosal cells (Simpson and McKie, 2009; Andrews, 2010).
Key aspects of cellular iron metabolism are controlled by
iron regulatory proteins (IRPs) 1 and 2 (a.k.a. ACO1 and IREB2,
respectively) (Anderson et al., 2012; Hentze et al., 2010). In
iron-deficient cells, both IRPs interact with cis-regulatory iron-
responsive elements (IREs) in the 50 UTR of the ferritin H- and
L-chain messenger RNAs (mRNAs) to inhibit their translation,
while their binding to the multiple IRE motifs within the 30 UTR
of the transferrin receptor 1 (TFR1, a.k.a. TFRC) mRNA prevents
its degradation. IRE motifs have been identified in other tran-
scripts, including the DMT1, FPN (Abboud and Haile, 2000;
Donovan et al., 2000; Gunshin et al., 1997; McKie et al., 2000),
and HIF2a mRNAs (Sanchez et al., 2007), and the recent
description of a whole-transcriptome repertoire of potential
novel IRP targets suggests that IRP function extends beyond
iron metabolism regulation (Sanchez et al., 2011). Both IRP1
and IRP2 are expressed in duodenal enterocytes, where they
have been proposed to sense the body’s iron demand (Schu¨-
mann et al., 1999). This, together with the presence of IRE motifs
in mRNAs encoding key players in intestinal iron metabolism
(DMT1, FPN, ferritin, HIF2a), raises the question of the role of
the IRP/IRE regulatory network in iron absorption. Constitutive,
body-wide disruption of IRP function in the mouse revealed
that IRP1 and IRP2 can largely replace each other, but are in
combination essential (Galy et al., 2008; Meyron-Holtz et al.,
2004; Smith et al., 2006). Using Cre/Lox technology, live mice
with constitutive intestinal deficiency for both IRPs starting at
midgestation have been generated (Galy et al., 2008). However,
these animals succumb perinatally due to severe malabsorption,
leaving the question of the role of the IRP/IRE system in iron
absorption and its interplay with systemic regulation in adult-
hood unanswered.
Here, we take advantage of a ligand-inducible, intestine-
specific Cre-deletor strain to coablate both IRPs in the gut
epithelium of normally developed adult mice. We show that
IRPs limit a mucosal block imposed by ferritin, allowing efficient
passage of iron across absorptive enterocytes. We also provide
key insights into the molecular control of basolateral and apical
iron transport by IRPs and uncover principles of the interplay
between local regulation by the IRP/IRE system and distal
control by systemic cues in the adjustment of iron absorption
upon changes in body iron requirements.
RESULTS
The IRP/IRE System Secures Sufficient Iron Absorption
in Adult Animals
Mice homozygous for floxed Aco1 and Ireb2 alleles
(Aco1flox/flox,Ireb2flox/flox) (Galy et al., 2005a) were bred to a
transgenic line (Vil-Cre-ERT2) expressing a tamoxifen (TMX)-
dependent Cre recombinase under the control of the Villin
promoter in the gut epithelium (el Marjou et al., 2004). Because
the Vil-Cre-ERT2 line is active in the stem cell compartment,
recombined loci persist for several weeks after Cre induction
in spite of rapid and constant intestinal cell renewal; note,
however, that the recombination efficiency is below 100%
and that the proportion of daughter cells lacking Cre recom-
bination increases over time after treatment (Figure S1). As ex-
pected, Aco1flox/flox,Ireb2flox/flox,Vil-Cre-ERT2 mice (designated
IrpVilCreER(+)) are born at Mendelian ratios and reach adulthood
without any abnormalities. To trigger intestinal IRP ablation in
adult animals, 10- to 12-week-old IrpVilCreER(+) micewere injected
with 1 mg TMX on 5 consecutive days; control animals received
vehicle only. Aco1flox/flox,Ireb2flox/flox control littermates (desig-
nated IrpVilCreER()) were subjected to the same regimen to
control for potential effects of TMX or the Cre transgene per
se. We observed efficient Cre-mediated truncation of both
the floxed Aco1 and Ireb2 alleles in the intestinal mucosa of
IrpVilCreER(+) mice as early as 3 days (Figure 1A) and up to 5weeks
(not shown) after TMX injection; no Cre recombination was
detected in nonintestinal tissues or in the gut of mice exposed
to vehicle only (Figure 1A).
Constitutive disruption of intestinal IRP function during embry-
onic development results in perinatal death and is associated
with severe growth defects, diarrhea, signs of dehydration, andmarked alterations of the villus architecture (Galy et al., 2008).
Contrasting with this, ligand-inducible disruption of IRP function
in the adult intestine causes a moderate reduction of body
weight evident 5 weeks after IRP ablation (Figure 1B) and no
histological sign of intestinal dysmorphia (Figure 1G). Clinical
chemistry parameters remain within the nonpathological range,
with only a slight decrease in total protein levels at the 5 week
time point (Table S1); of note, TMX alone exerts a mild effect
on some parameters, such as cholesterol levels. The IrpVilCreER
line thus enables highly tissue-specific and tightly ligand-depen-
dent disruption of intestinal IRP function in adult animals without
major adverse effects on mouse physiology, at least within a
5 week time course.
To explore the impact of intestinal IRP ablation on systemic
iron metabolism of the adult mouse, we analyzed hematological
and plasma iron parameters (Table 1), hepcidin mRNA expres-
sion in the liver (Figure 1C), as well as the splenic and hepatic
iron stores (Figure 1D). Compared to control groups, mice
with intestinal IRP deficiency display normal hemoglobin
values but significantly lower plasma iron concentration 5 weeks
after IRP ablation (Table 1). Intestinal IRP ablation per se
appears not to affect hepcidin expression (Figure 1C) or the
iron content of the spleen and liver within the time course of
the study (Figure 1D); note, however, that TMX treatment itself
triggers a transient decrease in hepcidin mRNA (Figure 1C) and
splenic iron levels (Figure 1D, top) 1 week after injection as well
as a minor tendency for liver iron loading (Figure 1D, bottom) at
the 2 and 5 week time points. These pharmacological effects
could potentially mask discrete alterations from enteric IRP
deficiency on such body-iron indices. Yet the extent and/or
duration of plasma iron reduction is not likely to affect hepcidin
expression as mice display no signs of increased erythropoiesis
at 5 weeks.
Decreased plasma iron concentration in mice with intestinal
IRP deficiency (Table 1) could possibly be explained by impaired
dietary iron intake. We therefore assessed iron absorption by
measuring whole-body retention of 59Fe 6 hr and 7 days after
gavage of a single dose of 59Fe(III); the gavage was performed
2 weeks after intestinal IRP ablation (i.e., past the transient
effects of TMX on hepcidin and splenic iron at the 1 week time
point; Figures 1C and 1D) and before the bodyweight loss result-
ing from intestinal IRP deficiency is manifest (5 week time point,
Figure 1B). Compared to control animals that received vehicle
only, IrpVilCreER(+) mice injected with TMX display reduced body
59Fe retention (Figure 1E, top); this effect is likely underestimated
due to a slight stimulatory effect of TMX on iron retention per
se. Interestingly, decreased 59Fe retention is associated with a
tendency for increased mucosal 59Fe levels 6 hr after gavage
(Figure 1E, bottom); 7 days after gavage, mucosal 59Fe accumu-
lation is no longer observed, plausibly due to epithelial cell
sloughing. Intestinal iron retention is further evidenced by a rise
in steady-state total nonheme iron levels in whole duodenal
lysates (Figure 1F). Perl’s staining reveals iron deposits in the
duodenal villi but not the crypts (Figure 1G), suggesting that
intestinal iron loading results from impaired transfer of dietary
iron to the bloodstream rather than increased uptake of plasma
iron via TFR1, which is preferentially expressed in crypt cells
(Schu¨mann et al., 1999). Altogether, these results demonstrateCell Reports 3, 844–857, March 28, 2013 ª2013 The Authors 845
Figure 1. Systemic Impact of Ligand-Induc-
ible Disruption of Intestinal IRP Function in
Adult Mice
(A) Recombination of the floxed Irp alleles was
detected by genomic PCR in duodenal scrapings
3 days after tamoxifen (TMX) induction of Cre
activity. The floxed (flox) and truncated (D) Aco1
(Irp1) and Ireb2 (Irp2) alleles, respectively, are
shown. Controls consisted of mice that did not
receive TMX and/or that lacked the Vil-Cre-ERT2
transgene (Cre-ER), as indicated.
(B–D) The impact of intestinal IRP ablation on body
weight (B, box and whiskers with minimum to
maximum values), liver hepcidin mRNA expres-
sion (C), and nonheme iron levels in spleen and
liver (D) was analyzed 1, 2, or 5 weeks after Cre
stimulation, as indicated. Hepcidin expression
was calibrated to b-actin mRNA.
(E) Analysis of whole-body 59Fe retention (top) 6 hr
and 7 days after gavage of a single dose of
radioiron reveals a tendency for reduced iron
absorption in mice with intestinal IRP deficiency,
associated with increasedmucosal 59Fe levels 6 hr
after gavage (bottom).
(F and G) Total nonheme iron measurements
confirm duodenal iron loading (F); enhanced Perl’s
staining with hemalaun counterstain (G) shows
iron deposits in duodenal villi of IrpVilCreER(+) mice
injected with TMX versus vehicle 2 weeks after
injection; scale bar: 100 mm.
(C–F) Data (mean ±SEM) are presented as
percentage of control (i.e., IrpVilCreER() mice
injected with vehicle) within each group. The
number of mice (n) is indicated. Probability values
were determined by a one-way ANOVA with the
Bonferroni post hoc test (*p < 0.05, **p < 0.01,
***p < 0.001).
See also Figure S1 and Table S1.that intestinal IRP expression is required for appropriate iron
absorption in adult mice under standard laboratory conditions.
IRPs Limit a Ferritin-Imposed Mucosal Block
Decreased iron absorption combinedwithmucosal iron retention
in mice with enteric IRP deficiency (Figures 1E–1G) indicates that
IRPsare required for sufficient iron transfer across theenterocyte.
To delineate the molecular mechanism(s) by which IRPs regulate
intestinal iron fluxes, we analyzed the expression of ironmanage-
ment molecules in the duodenum 1, 2, and 5 weeks after IRP
ablation. TFR1 expression is reduced both at the protein and
mRNA level, while ferritin L (FTL1) protein expression is increased
(Figures 2A and 2B). The increase in FTL1 expression is largely
accounted for by translational derepression (see Figure 3B),846 Cell Reports 3, 844–857, March 28, 2013 ª2013 The Authorsalthough increases in FTL1 mRNA levels
at the 2 and 5 week time points appear
to contribute (Figure 2B); decreased
FTL1 protein turnover could further lead
to increased ferritin expression.
Decreased iron transfer across IRP-
deficient enterocytes could be due to
decreased iron efflux via the FPN exportchannel (Donovan et al., 2005). However, mice with intestinal
IRP deficiency display marked FPN upregulation at the posttran-
scriptional level (Figure 2; see also Figure 3B). Moreover, the
expression of the FPN-cofactor hephaestin (Vulpe et al., 1999)
is normal or even slightly elevated (Figure S2). Impairment of
iron efflux via FPN is thus unlikely. Surprisingly, protein levels
of the apical iron importer DMT1 are augmented (Figure 2A);
this is accompanied by selective upregulation of the DMT1
mRNA isoform bearing an IRE in its 30 UTR but not of its non-
IRE (noIRE) counterpart (Figure 2B). The apical iron reductase
DCYTB is also upregulated (Figure 3A). Hence, IRP-deficient
enterocytes have high levels of both apical and basolateral iron
transport molecules, which would be predicted to enhance iron
absorption rather than impair mucosal iron transfer.
Table 1. Plasma Iron and Hematological Parameters of Mice with Intestinal IRP Deficiency
1 Week 2 Weeks 5 Weeks
Cre-ER   + +   + +   + +
TMX  +  +  +  +  +  +
Plasma Iron Chemistry
n 6 7 5 9 7 6 5 7 9 11 11 12
Plasma iron (mmol/l) 36.1 ± 2.3 32.5 ± 2.0 31.7 ± 4.2 36.4 ± 4.3 38.4 ± 4.9 47.0 ± 7.6 40.2 ± 4.1 30.6 ± 1.7 33.5 ± 3.1 31.2 ± 2.4 34.5 ± 1.8 25.3a ± 1.5
TIBC (mmol/l) 108.4 ± 4.7 90.3 ± 4.4 102.8 ± 6.1 99.7 ± 4.6 87.0 ± 6.9 103.2 ± 6.5 99.4 ± 8.5 85.5 ± 1.7 84.4 ± 3.5 80.7 ± 2.3 86.3 ± 3.4 76.6 ± 3.7
Tf. sat. (%) 33.1 ± 1.1 36.0 ± 1.8 30.3 ± 2.2 35.8 ± 3.3 44.3 ± 4.6 44.5 ± 4.9 41.3 ± 5.7 35.6 ± 1.5 39.2 ± 2.4 38.3 ± 2.6 40.0 ± 1.7 33.7 ± 2.3
n 8 8 10 15 9 9 6 11 12 13 15 17
Ferritin (ng/l) 193 ± 17 115b ± 11 188 ± 21 117b ± 7 152 ± 15 158 ± 11 182 ± 18 176 ± 11 172 ± 5 235b ± 12 201 ± 14 258c ± 15
Hematological Parameters
n 13 13 12 12 13 14 10 8 15 16 17 18
WBC (109/l) 9.5 ± 1.0 7.4 ± 0.7 7.7 ± 0.8 7.6 ± 1.1 10.0 ± 1.3 11.1 ± 1.9 11.7 ± 1.8 12.4 ± 1.5 8.9 ± 1.1 8.6 ± 1.2 8.5 ± 0.8 10.6 ± 1.6
RBC (1012/l) 10.1 ± 0.1 10.0 ± 0.1 10.3 ± 0.1 10.0 ± 0.1 10.0 ± 0.2 9.8 ± 0.2 9.8 ± 0.3 10.2 ± 0.1 10.0 ± 0.3 10.2 ± 0.2 10.1 ± 0.2 10.2 ± 0.2
Hb (g/l) 145 ± 2 148 ± 2 147 ± 2 145 ± 3 147 ± 1 150 ± 2 146 ± 2 150 ± 2 143 ± 3 148 ± 2 147 ± 2 142 ± 2
Hct (%) 51.7 ±0.7 52.2 ±0.6 52.9 ±0.5 51.9 ±0.6 51.0 ± 0.9 52.0 ± 1.0 51.0 ± 1.6 53.7 ± 0.6 50.9 ± 1.3 52.6 ± 1.1 51.5 ± 1.0 50.1 ± 0.9
MCV (fl) 51.4 ± 0.2 52.4c ± 0.2 51.1 ± 0.1 51.7 ± 0.1 51.3± 0.2 52.9c ± 0.2 51.8 ± 0.4 52.6b ± 0.3 51.1 ± 0.2 51.8 ± 0.2 51.1 ± 0.2 49.7c ± 0.3
Mice carrying floxed Irp alleles together with or without the Vil-Cre-ERT2 transgene (Cre-ER) received either tamoxifen (TMX) or vehicle, and plasma iron and hematological parameters were
determined 1, 2, or 5 weeks later, as indicated. Data are given as averages ± SEM. The sample size (n) is indicated. Probability values were determined by a one-way ANOVA with a Bonferroni
post hoc comparison to IrpVilCreER() mice injected with vehicle. Note that plasma ferritin is decreased by TMX alone 1 week and increased 5 weeks after treatment.
Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; RBC, red blood cell; TIBC, total iron binding capacity; Tf. sat., transferrin saturation; WBC, white blood cell.
ap < 0.05.
bp < 0.01.
cp < 0.001.
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Figure 2. Expression of Iron AbsorptionMolecules in the Duodenum
(A) Representative western blot analysis of duodenal ferritin (FTL1), TFR1,
FPN, DMT1 expression 1, 2, and 5 weeks after IRP ablation in the intestinal
epithelium. Two samples per experimental group are shown; b-actin (ACTB)
was monitored to ascertain equal loading.
(B) The expression of the corresponding mRNAs was assayed by qPCR, with
selective analysis of the DMT1-IRE and DMT1-noIREmRNA isoforms. FTL and
TFR1 mRNA expression was calibrated to b2-microglobulin mRNA; FPN and
DMT1 mRNAs were normalized to tubulin. Data (mean ±SEM) are presented
as percentage of control (i.e., IrpVilCreER() mice injected with vehicle) within
each group. The number of animals (n) is indicated. Probability values were
determined by a one-way ANOVA with the Bonferroni post hoc test (*p < 0.05,
**p < 0.01, ***p < 0.001).
See also Figures S2 and S3.
848 Cell Reports 3, 844–857, March 28, 2013 ª2013 The AuthorsGenetic perturbation of ferritin function in the mouse intestine
revealed that mucosal ferritin can limit basolateral iron export
(Vanoaica et al., 2010). Note that IRP-deficient enterocytes
highly overexpress ferritin (Figure 2A). Furthermore, the excess
of ferritin is able to assemble into multimers (Figure S3), which
represent the iron-sequestering form of the protein (Theil,
2011). Impaired iron absorption and mucosal iron loading in
mice with enteric IRP deficiency could therefore be accounted
for by the diversion of iron transiting through enterocytes into
overabundant ferritin nanocages. Rather surprisingly, drastic up-
regulation of DMT1 and FPN per se does not enforce effective
iron transfer through enterocytes. Our data reveal that their over-
expression can actually be associated with insufficient transfer
when ferritin is hyperinduced.
IRPs Control Apical Iron Transport via HIF2a
The increased expression of DMT1 in IRP-deficient enterocytes
of adult animals (Figure 2) was rather unexpected because (1)
analogous to TFR1, lack of IRP interaction with the 30 UTR IRE
of the DMT1 transcript would be anticipated to destabilize the
mRNA (Casey et al., 1989; Mu¨llner et al., 1989); and (2) the selec-
tive downregulation of the DMT1-IRE mRNA isoform in the
duodenum of suckling mice with constitutive IRP deficiency in
the intestine (Galy et al., 2008) indicated that IRPs indeed exert
a positive effect on enterocytic DMT1 via the IRE, at least during
early life. How could such a putative decrease in DMT1 mRNA
stability be overridden?
Stimulation of DMT1 could possibly be mediated by HIF2a,
which has been shown to control DMT1 transcription in the gut
(Mastrogiannaki et al., 2009; Shah et al., 2009). Importantly,
DMT1 transcription occurs from two alternative promoters
termed 1A and 1B, respectively, yielding DMT1 mRNA variants
that differ in their 50 region (Hubert and Hentze, 2002); HIF2a
binds to and stimulates the 1A but not the 1B promoter (Mastro-
giannaki et al., 2009; Shah et al., 2009). Interestingly, IRP abla-
tion in the adult intestine triggers the selective upregulation
of the DMT1-1A mRNA isoform but not of its 1B counterpart
(Figure 3A); Dcytb, another direct HIF2a-target gene in the
duodenum (Mastrogiannaki et al., 2009; Shah et al., 2009), is
also upregulated (Figure 3A). Although we could not directly
assess HIF2a protein expression by western blotting, these
data thus suggest that increased DMT1 expression in IRP-defi-
cient enterocytes could ensue from enhanced HIF2a function.
How could HIF2a function increase in IRP deficiency?
The HIF2a mRNA bears an IRE in its 50 UTR that mediates
translational repression (Sanchez et al., 2007; Anderson et al.,
2013; Ghosh et al., 2013). To test whether IRP deficiency alters
HIF2a translation in the intestine, we determined the polysomal
association of HIF2a mRNA using sucrose density gradients
(Figure 3B). As negative controls, we analyzed the ACTB (b-actin)
and GAPDH (glyceraldehyde-3-phosphate dehydrogenase)
mRNAs from the same fractions; as positive controls, we
assayed FTL1 and FPN. While approximately 85% of both the
ACTB and GAPDH mRNAs sediment in dense, polysomal frac-
tions regardless of the IRP status, the FTL1 and FPN mRNAs
shift from nonpolysomal (NP) to polysomal (P) fractions upon
IRP ablation (FTL1 P/NP ratio of 0.6 ± 0.2 versus 14.1 ± 5.3
and FPN P/NP ratio of 0.6 ± 0.1 versus 3.9 ± 1.4 in IRP-deficient
versus control mice, respectively); the distribution of mRNAs
with 30 UTR IREs (TFR1, DMT1-IRE) across the sucrose gradient
is unchanged, as expected (not shown). In control mice, the
HIF2amRNA appears to be more actively translated (P/NP ratio
2.5 ± 0.4) than the FTL1 and FPN mRNAs. However, the propor-
tion of HIF2a mRNA in NP fractions drops from 30% to 15%
upon IRP disruption, showing that IRPs repress HIF2a transla-
tion in the duodenum. Enhanced HIF2a function in IRP-deficient
enterocytes thus results, at least in part, from derepression of
HIF2a mRNA translation.
Our data thus implicate the IRPs in the control of DMT1 expres-
sion via two distinct, antagonistic mechanisms: direct, positive
control via the 30 UTR IRE (Galy et al., 2008), and a negative con-
trol circuit of DMT1 transcription through repression of HIF2a
translation (Figure 3), respectively. A key question is whether
these two pathways act in isolation or cooperate to modulate
DMT1 levels. To address this, we selectively determined the ex-
pression of each of the four DMT1mRNA isoforms. We assumed
that IRP deficiencywould result in lower expression of the 1A and
1B variants bearing the IRE compared to their IRE-less counter-
parts if IRPs stabilize the DMT1 mRNA through the 30 UTR IRE.
The IRE and noIRE DMT1 mRNA isoforms, respectively, were
reverse transcribed in separate reactions using isoform-specific
reverse transcription (RT) primers, followed by quantitative real-
time PCR (qPCR) determination of DMT1-1A versus DMT1-1B;
IRE and noIRE levels were also assayed to assess RT primer
specificity. As expected, the IRE and noIRE qPCRs, respectively,
yielded background signals (i.e., comparable to signals obtained
without adding primers to the RT) from RT reactions primed with
noIRE- versus IRE-specific oligonucleotides (Figure 3C, top
histograms). While the IRE RT-qPCR recapitulates the DMT1-
IRE mRNA upregulation (Figure 3C, top histogram) observed
with complementary DNA (cDNA) generated using random
primers (see Figure 2B), DMT1-noIRE mRNA levels remain
unchanged (Figure 3C). Importantly, IRP disruption upregulates
the 1A mRNA isoforms regardless of the presence of the 30
UTR IRE (Figure 3C); the IRE does not affect 1B expression either
(Figure 3C, bottom histogram). Hence, in adult mice, the IRPs
seem not to influence basal DMT1 mRNA expression through
the 30 UTR IRE. This contrasts with the situation in early life,
where intestinal IRP ablation causes a 2.5-fold decrease in the
expression of the 1B-IRE but not the 1B-noIRE mRNA (Fig-
ure S4); 1A-IRE mRNA is expressed below the detection limit
in these animals. The function of the IRE in the 30 UTR of the
DMT1 mRNA thus appears to be developmentally controlled,which explains the discrepant impact of IRP deficiency on
DMT1 in adulthood versus early life.
Thus, in adult mice, IRPs regulate apical iron uptake indirectly
via modulation of HIF2a translation.
The IRP/IRE System Defines a Regulatory Set Point for
Intestinal Iron Absorption
IRPs govern the steady-state expression of key iron absorption
molecules in the duodenum (Figures 2 and 3). Whether and
how the IRP/IRE system contributes to the modulation of intes-
tinal iron absorption in response to changes in organismal iron
needs is not known. To address this, we analyzed the impact
of intestinal IRP deficiency on the expression of iron absorption
molecules (DMT1, DCYTB, FPN, ferritin) in the duodenum of
mice subjected to regimens that either enhance or reduce,
respectively, the body iron demand. Two weeks after IRP abla-
tion, mice were injected with erythropoietin (EPO) to stimulate
erythropoiesis and thus augment body iron needs (Figure 4);
alternatively, they received parenteral doses of Fe-dextran to
raise systemic iron levels and thereby diminish the alimentary
iron demand (Figure 5). Reticulocyte counts confirm a compa-
rable EPO response across all experimental groups (Figure 4A,
top). Clearly, stimulation of erythropoietic activity leads to
decreased hepcidin mRNA expression in the liver (Figure 4A,
bottom); of note, TMX per se slightly counteracts hepcidin down-
regulation. Conversely, Fe-dextran injection causes liver iron
loading (Figure 5A, top) and hepcidinmRNA induction (Figure 5A,
bottom), with a minor additive effect of TMX alone on hepcidin
mRNA expression.
EPO stimulation increases DMT1 protein expression in the
duodenum of control mice (i.e., IrpVilCreER() mice injected with
TMX or vehicle, respectively, and IrpVilCreER(+) animals injected
with vehicle; Figure 4B, top) associated with upregulation of the
DMT1-IRE and DMT1-1AmRNA variants (Figure 4B, histograms);
DMT1-noIRE mRNA expression remains unchanged, while 1B
mRNA levels are slightly decreased. DCYTB mRNA levels are
also augmented, which together with the selective upregulation
of the DMT1-1A mRNA isoform may reflect stimulation of Dmt1
and Dcytb transcription by HIF2a. Importantly, IRP ablation does
not interfere with EPO stimulation of DMT1 protein expression or
with the upregulation of the DMT1-1A, DMT1-IRE, and DCYTB
mRNAs (Figure 4B). However, the combination of increased basal
expression with upregulation in response to EPO yields higher
levels of the DMT1-IRE and DCYTB mRNAs in IRP-deficient
mice compared to EPO-treated control animals (Figure 4B).
Similar to DMT1, EPO administration elicits a marked increase
in duodenal FPN protein expression in an IRP-independent
manner (Figure 4C, top). FPN upregulation most likely reflects
decreased protein turnover as a result of hepcidin downregula-
tion (Figure 4A), although transcriptional stimulation could also
contribute (Figure 4C, bottom). EPO treatment also decreases
duodenal ferritin levels (Figure 4D, top). Ferritin expression is
reduced posttranscriptionally (Figure 4D, bottom) but indepen-
dent of IRP function, as EPO is able to reduce ferritin protein
expression in IRP-deficient animals (Figure 4D, top). Among
other possibilities, ferritin downregulation could be due to in-
creased proteasomal degradation as a result of iron mobilization
by the FPN export channel (De Domenico et al., 2006). FerritinCell Reports 3, 844–857, March 28, 2013 ª2013 The Authors 849
Figure 3. Control of Apical Iron Transport by IRPs
(A) qPCR analysis of DMT1-1A, DMT1-1B, and DCYTB mRNAs expression (normalized to tubulin) in the duodenum of mice 2 weeks after intestinal IRP ablation.
Data (mean ±SEM, n = 6) are presented as percentage of control (i.e., IrpVilCreER() mice injected with vehicle).
(legend continued on next page)
850 Cell Reports 3, 844–857, March 28, 2013 ª2013 The Authors
levels in EPO-treated mice nonetheless remain markedly ele-
vated in IRP-deficient versus control animals due to dramatically
elevated basal expression (Figure 4D, top).
Contrasting with EPO treatment, body iron loading decreases
DMT1 and FPN protein levels in the duodenum (Figures 5B and
5C, top) associated with reduced expression of the DMT1-1A
and DMT1-IRE mRNA isoforms (Figure 5B, histograms) and
mild FPN mRNA downregulation (Figure 5C, histogram), respec-
tively. DCYTB mRNA levels are also diminished (Figure 5B,
bottom histogram). Mice with intestinal IRP deficiency respond
to body iron loading with efficient DMT1, FPN, and DCYTB
downregulation. However, they fail to tune down the expression
of those molecules to the levels observed in control animals
because of the initially high expression levels under basal condi-
tions (Figures 5B and 5C). This is particularly evident for FPN,
whose protein expression in iron-loaded mice is similar if not
slightly higher than FPN expression in control animals injected
with dextran alone. In control mice, ferritin expression is slightly
augmented upon systemic iron loading (Figure 5D), likely reflect-
ing the physiological IRP/IRE-mediated response. Consistent
with this, body iron loading did not trigger ferritin upregulation
in IRP-deficient mice (Figure 5D) with already nearly complete
derepression of basal ferritin mRNA translation (Figure 3B).
These data uncover that the regulated intestinal response to
increased erythroid iron requirements or to body iron overload
is IRP independent (at least under the experimental conditions
used in this study). However, alteration of the basal set
points for iron-absorption molecules in IRP-deficient entero-
cytes results in inadequate expression of those molecules in
conditions of body iron loading and erythropoietic stimulation,
respectively. IRPs thus define a basal set point for iron absorp-
tion upon which regulation in response to systemic cues is
superimposed in an IRP-independent manner.
DISCUSSION
The interaction between the hepatic hormone hepcidin and its
receptor FPN is currently being viewed as the key determinant
of the regulation of duodenal iron absorption. Yet, with the
exception of hephaestin, all major iron metabolism molecules
expressed in the intestine and known to be crucial for iron assim-
ilation in mice (i.e., DMT1, HIF2a, ferritin, and FPN itself) (Dono-
van et al., 2005; Gunshin et al., 2005; Mastrogiannaki et al., 2009;
Shah et al., 2009; Vanoaica et al., 2010), are encoded by IRE-
containing mRNAs. Therefore, the hepcidin/FPN and IRP/IRE
systems intersect at the level of enterocytes and their respec-(B) IrpVilCreER(+) mice were injected with TMX versus vehicle. Two weeks later, extr
density gradients and 12 fractions were collected with constant UV recording (to
each fraction was determined by qPCR. The curves (left) represent mRNA leve
fractions. The histograms (right) show the amount of mRNA (mean ±SEM) in poly
(C) The Dmt1 gene (schematized on the top) gives rise to four mRNA isoforms vi
selectively controls the transcription of the 1A (but not 1B) isoforms. The IRE is loca
subsequently amplified by qPCR are depicted. Samples from IrpVilCreER(+) mice w
above each histogram) using DMT1-IRE (left bars) versus noIRE (right bars)
(mean ±SEM, n = 6) are presented as percentage of control (i.e., IrpVilCreER(+) mice
noIRE- or the IRE-specific RT primers, as indicated in the legend of vertical axes
Probability values were determined by a one-way ANOVAwith the Bonferroni pos
See also Figure S4.tive roles need to be understood. The functional redundancy
between IRP1 and IRP2 has masked their importance for dietary
iron uptake, and adults retaining either of the two proteins
display normal iron absorption under standard laboratory condi-
tions (Galy et al., 2005b; Meyron-Holtz et al., 2004). Through
inducible coablation of both IRPs in the adult intestine, this
work uncovers that IRP expression in enterocytes is critically
important for iron assimilation and that both humoral regulation
by hepcidin and cell-autonomous local control by the IRP/IRE
system must function properly for adequate regulation of key
iron absorption molecules in the duodenum.
Intersection of Hepcidin and IRP Regulation
One obvious point of intersection between the ‘‘cellular’’ IRP/IRE
systemand the systemic regulator hepcidin is FPN. Thepresence
of an IRE in the 50 UTR of the mRNA encoding the hepcidin
‘‘receptor’’ FPN would predict FPN translation to be inhibited
when enterocytes are iron deprived, which seems inconsistent
with the observed augmentation of duodenal FPN levels in iron
deficiency (Abboud and Haile, 2000; McKie et al., 2000). This
apparent contradiction has been explained by the expression of
intestinal FPN mRNA isoforms that lack the 50 UTR IRE and thus
evade translational repression by the IRPs (Zhang et al., 2009).
However, Zhang et al. reported that such transcript variants
account for only 20%of total FPNmRNA expression under basal
conditions. Indeed, we find that the majority of FPN mRNA shifts
from nonpolysomes to polysomes upon IRP ablation, with only
a minor fraction (25%) apparently remaining insensitive to IRP
depletion. Furthermore, upregulation of the IRE-FPN mRNA in
the duodenum of iron-deficient mice was shown to exceed the
stimulation of the noIRE isoforms (Zhanget al., 2009). This implies
that theFPNmRNAcarrying the50UTR IREprevails even incondi-
tions of iron deficiency. Hence,most of the FPNmRNA is actually
subject to translational control by IRPs in the intestine. Although
increased FPN expression in iron-deficient enterocytes can
partially be explained by the expression of FPN mRNA variants
lacking an IRE, it could also reflect a dominant contribution of
hepcidin-dependent regulation of FPN turnover over translational
control by IRPs. IRPs nevertheless contribute to the control of
FPN levels in the duodenum, as evidenced by the failure of
mice with enteric IRP deficiency to fully repress FPN when
systemic iron administration triggers hepcidin expression.
IRP Regulatory Circuits Controlling DMT1
In contrast to FPN that responds directly to hepcidin, apical
DMT1 expression appears to be regulated locally by the amountacts from duodenal scrapings were resolved through linear 20%–50% sucrose
p). The amount of FTL1, FPN, HIF2a, b-actin (ACTB), and GAPDH mRNAs in
ls across the gradient as a percentage (mean ±SEM, n = 4) of the sum of all
some versus nonpolysome fractions (fractions 1–8 and 9–12, respectively).
a alternative usage of promoters, polyadenylation (pA), and splice sites. HIF2a
ted in the alternatively spliced exon 16. The primers used for RT and the regions
ere subjected to qPCR analysis of the four DMT1-mRNA variants (as indicated
isoform-specific primers (together with tubulin for calibration) for RT. Data
injected with vehicle) using as a reference the signals obtained either from the
. The ratios TMX/vehicle (mean ±SEM) are indicated for the 1A and 1B qPCR.
t hoc test (A) or the Student’s t test (B and C) (*p < 0.05, **p < 0.01, ***p < 0.001).
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Figure 4. IRP Function in the Regulation of
Iron Absorption in Response to Increased
Body Iron Requirements
(A–D) Mice carrying floxed Irp alleles together
or not with the Vil-Cre-ERT2 transgene (Cre-ER)
received either tamoxifen (TMX) or vehicle and
were further injected with EPO versus saline, as
indicated. As expected, EPO treatment increased
reticulocyte counts (A, top) and decreased hep-
cidin mRNA expression in the liver (A, bottom). A
representative western blot analysis of DMT1 (B),
FPN (C), and FTL1 (D) expression in the duodenum
is shown; b-actin (ACTB) was monitored to
ascertain equal loading. Two samples per experi-
mental group are displayed. The asterisk on the
right of the blot indicates a cross-reacting band.
The expression of the corresponding mRNAs
including all four DMT1 variants was assayed by
qPCR; DCYTB mRNA levels were also analyzed
(B). The expression of the DMT1, FPN, and DCYTB
mRNAs was calibrated to tubulin; FTL1 mRNA
was normalized to b2-microglobulin and hepcidin
mRNA to b-actin. Data (mean ±SEM) are pre-
sented as percentage of control (i.e., IrpVilCreER()
mice that did not receive TMX) within each group.
The sample size (n) is indicated. Probability values
were determined by a one-way ANOVA with the
Bonferroni post hoc test (*p < 0.05, **p < 0.01,
***p < 0.001).
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Figure 5. Role of the IRPs in the Modulation of Iron
Absorption Molecules upon Body Iron Loading
(A–D) Mice carrying floxed Irp alleles together with or
without the Vil-Cre-ERT2 transgene (Cre-ER) were injected
with either tamoxifen (TMX) or vehicle, and received
2 weeks later parenteral doses of iron dextran (Fe) versus
dextran alone, as indicated. Iron dextran triggered hepatic
iron loading (A, top) associated with increased hepcidin
mRNA expression (A, bottom). Representative western blot
analyses of DMT1 (B), FPN (C), and FTL1 (D) expression in
the duodenum are displayed together with b-actin (ACTB)
as a loading control. Two samples per experimental group
are shown. The expression of the corresponding mRNAs,
including all four DMT1 variants, was determined by qPCR;
DCYTB mRNA levels were also analyzed (B). The expres-
sion of the DMT1, FPN, and DCYTBmRNAs was calibrated
to tubulin; FTL1 mRNAwas normalized to b2-microglobulin
mRNA and hepcidin to b-actin. Data (mean ±SEM) are
presented as percentage of control (i.e., IrpVilCreER() mice
that did not receive TMX) within each group. The sample
size (n) is indicated. Probability values were determined by
a one-way ANOVA with the Bonferroni post hoc test (*p <
0.05, **p < 0.01, ***p < 0.001).
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of iron within enterocytes (Chen et al., 2003; Frazer and Ander-
son, 2003). Because IRPswould be anticipated to exert a positive
effect on DMT1 mRNA expression via its 30 UTR IRE, they have
been proposed to coordinate apical iron uptake with the humoral
regulation of basolateral iron export (Chen et al., 2003; Frazer
and Anderson, 2005). According to this model, inhibition of
FPN-mediated iron export by hepcidin would increase iron levels
within enterocytes, reduce IRP activity, and thus decrease DMT1
mRNA levels (and correspondingly when basolateral iron efflux
diminishes).
Our data challenge such a model because mice with intestinal
IRP deficiency retain their ability to upregulate DMT1 upon stim-
ulation of erythroid iron requirements. Remarkably, we found
that IRPs do not exert a positive effect on DMT1 in the intestine
of adult mice but actually repress its expression. This effect is
indirect and at least in part due to translational repression of
the HIF2a mRNA. HIF2a expression in enterocytes mediates
the transcriptional upregulation of DMT1 in the duodenum of
mice fed an iron-deficient diet (Taylor et al., 2011) or in hemolytic
animals with a high erythroid demand for iron (Anderson et al.,
2011). How exactly changes in body iron needs are conveyed
to the HIF2a pathway in intestinal epithelial cells remains incom-
pletely understood, but could in part rely on prolyl-hydroxylases
(PHDs) that promote HIF2a decay in an iron- and oxygen-depen-
dentmanner (Kaelin andRatcliffe, 2008). In animals with high iron
needs, a reduction of PHD activity in iron-depleted enterocytes
would be anticipated to increase HIF2a. Conversely, concomi-
tant IRP activation might inhibit HIF2a translation and thus
antagonize the transcriptional stimulation of apical iron uptake.
Yet IRP disruption does not interfere with DMT1 induction in
EPO-treated mice. Hence, while IRPs control basal HIF2a ex-
pression in the duodenum, IRP regulation of HIF2a translation
in response to acute changes in systemic iron needs might
be counteracted by dominant effects exerted, for example, by
PHDs. In principle, the HIF2a-mediated regulation of Dmt1 tran-
scription by IRPs could also be mitigated by concomitant stabi-
lization of the DMT1 mRNA via its 30 UTR IRE. However, unlike in
suckling pups, we found that this 30 UTR IRE does not influence
DMT1 mRNA expression in the adult intestine. Reminiscent of
the differentiation-stage-specific regulation of TFR1 in erythroid
cells (Lobmayr et al., 2002), the regulatory role of the DMT1
mRNA IRE thus appears to be context dependent in vivo, being
active during early life but silent in adulthood, at least in the
duodenum and under the experimental conditions used in this
study. The context-dependent activity of the DMT1 IRE may
also explain why previous attempts to demonstrate its functional
role in mediating iron regulation of a reporter gene in cultured cell
lines have failed (Tchernitchko et al., 2002; Zoller et al., 2002).
Rebirth of the Mucosal Block
We found that IRPs inhibit the expression of both FPN and DMT1
(most likely via HIF2a) in adult mice. Although we cannot formally
conclude that the upregulation of these iron transporters in
IRP-deficient mice yields a commensurate increase in their
activity, these responses would be expected to stimulate dietary
iron assimilation. However, contrary to expectation, IRP ablation
results in decreased iron absorption and iron retention in enter-
ocytes. Ferritin was proposed to impose a mucosal block to854 Cell Reports 3, 844–857, March 28, 2013 ª2013 The Authorsiron absorption more than half a century ago (Granick, 1946),
and enterocytic ferritin can limit dietary iron intake (Vanoaica
et al., 2010). Our data now show that mice lacking enterocytic
IRP activity fail to absorb adequate amounts of iron in spite of
the high expression levels of the iron transporters DMT1 and
FPN. The most plausible explanation for this mucosal block in
IRP-deficient mice is iron withholding by the large excess of
mucosal ferritin. If true, genetic ablation of ferritin in enterocytes
of mice with intestinal IRP deficiency would be anticipated to
alleviate the mucosal block, at least partially. Of note, the reduc-
tion of 59Fe absorption in IRP-deficientmice is relatively limited in
regard of the vast excess of mucosal ferritin. This suggests that
only a minor fraction of the iron transiting through enterocytes is
actually trapped by ferritin, possibly due to limiting amounts and/
or activity of the factors required for iron loading onto ferritin such
as poly (rC)-binding protein 1 (Shi et al., 2008). IRPs thus have
a dual function in the regulation of iron absorption: they limit
apical and basolateral iron transport and also ensure sufficient
passage of iron through the enterocyte by counteracting the
diversion of the metal into ferritin. As such, IRPs define an enter-
ocytic ‘‘basal state’’ for iron absorption upon which hepcidin-
mediated systemic regulation in response to stimuli such as
enhanced erythropoiesis or acute iron loading is superimposed
(Figure 6).
EXPERIMENTAL PROCEDURES
Mice and Treatments
For all studies of IrpVil-CreER(+) mice, control animals consisted of IrpVil-CreER()
littermates subjected to the very same regimen. To trigger IRP ablation in
the intestine of adult mice, 10- to 12-week-oldmales received intraperitoneally
(i.p.) 1 mg TMX (T5648; Sigma-Aldrich, Taufkirchen, Germany; 10 mg/ml in
sunflower seed oil:ethanol 9:1) per day versus vehicle only on 5 consecutive
days. To stimulate erythropoiesis, mice were injected daily (i.p.) with 50 U
EPO (ERYPO; Janssen-Cilag GmbH, Neuss, Germany) or 0.9% NaCl on 3
consecutive days and were sacrificed 48 hr after the last EPO injection.
Secondary iron loading was achieved by injecting (i.p.) mice daily with 1 mg
iron dextran (D8517, Sigma) versus dextran alone (dextran5, 124325;
CHEMOS GmbH, Regenstaug, Germany) on 5 consecutive days; the animals
were sacrificed 5 days after the last injection. Mice were kept under a constant
light/dark cycle on a standard diet. For the analysis of intestinal iron transport
molecules and polyribosomes,mice were euthanized by cervical dislocation to
minimize protein and RNA degradation. Tissues were either used fresh (poly-
ribosome preparation) or flash-frozen in liquid nitrogen (RNA and protein
extraction). For other analyses, mice were sacrificed by CO2 inhalation and
heparinized blood was collected by cardiac puncture. Animal handling was
in accordance with approved guidelines of EMBL and the Technical University
of Munich.
Reticulocyte Counts
Blood reticulocytes were counted on blood smears stained with methylene
blue (performed by VetMedLabor, IDEXX Laboratories, Ludwigsburg,
Germany).
RNA Analysis
Total RNA was extracted from tissues with the TRIzol reagent (Invitrogen,
Karlsruhe, Germany). For standard qPCR analysis, total RNAwas reverse tran-
scribed using random primers and Superscript II DNA polymerase (Invitrogen)
according to the manufacturer’s instructions. For specific cDNA synthesis,
total RNA was reverse transcribed at 55C using the Transcriptor reverse
transcriptase (Roche, Mannheim, Germany) together with 0.5 mM of the
gene-specific primers listed in Extended Experimental Procedures. A reaction
lacking the gene-specific primers was performed in parallel to assess RT
Figure 6. The IRP/IRE System in the Regulation of Iron Absorption
and its Crosstalk with Hepcidin-Mediated Control Mechanisms
In duodenal enterocytes of adult mice, IRPs repress ferritin and ferroportin
(FPN) mRNA translation directly and exert a negative effect on DMT1 mRNA
levels through IRE-mediated translational inhibition of the HIF2a transcription
factor. Note that in suckling animals, IRPs also exert a direct, positive effect on
DMT1 mRNA levels (dashed line) via the IRE in the 30 UTR. Hepcidin down-
regulation in mice with high iron needs augments basolateral FPN-mediated
iron export. The ensuing cellular iron depletion activates the IRPs, which in turn
repress ferritin translation to allow efficient iron transfer across the enterocyte
(protein degradation can also contribute to ferritin downregulation). Cellular
iron depletion also increases HIF2a levels, most likely via inhibition of the iron-
dependent PHDs that promote HIF2a degradation; HIF2a activation stimulates
DMT1 transcription and apical iron uptake. The net increase in FPN and HIF2a
expression in spite of translational inhibition by activated IRPs reflects the
dominant contribution of the hepcidin-dependent regulation of FPN and the
PHD-dependent control of HIF2a turnover (note that a small fraction of FPN
mRNA lacks an IRE and escapes IRP inhibition). In IRP deficiency (bottom),
the translation of the HIF2a, FPN, and ferritin mRNAs is constitutively dere-
pressed. This leads to abnormally high expression of DMT1 (through gain of
HIF2a function) and FPN. In spite of high expression of both the apical and
basolateral iron transporters, the excess of translationally derepressed ferritin
impedes iron transfer across the cell by sequestering the metal, thereby
imposing a mucosal block. Although IRP-independent pathways remain
effective at modulating the expression of FPN (e.g., hepcidin), HIF2a (e.g.,
PHDs), and ferritin in response to changes in body iron needs, the loss of IRPs
causes higher expression of these molecules compared to wild-type animals.background. qPCR was performed using the ABI 7500 Real Time PCR System
and SYBR green (Applied Biosystems, Carlsbad, CA, USA) together with the
primers listed in Extended Experimental Procedures. For each sample, RTreactions were performed in duplicate and the average of the duplicate was
used for subsequent calculations. Each mRNA analyzed was calibrated to
a standard (ACTB, B2M, and TUBB5, respectively) with similar Ct (threshold
cycle) values, as indicated in figure legends. Additional standards were used
to ascertain steady expression of ACTB, B2M, and TUBB5 (not shown).
Protein Analysis
Tissue lysates were prepared as described previously (Galy et al., 2005b).
Immunoblotting was performed using the antibodies listed in Extended Exper-
imental Procedures.
Polyribosome Analysis
The first 4 cm of the duodenum was opened longitudinally and washed in ice-
cold buffer A (40 mM HEPES [pH 7.4], 100 mM KCl, 5 mM MgCl2, 2mM Na3-
citrate) containing 150 mg/ml cycloheximide. The duodenal mucosa was
scrapped off and immediately transferred to a Dounce homogenizer with
ice-cold buffer A containing 10mMDTT, 500 U/ml RNasin, and protease inhib-
itors (complete EDTA-free protease inhibitor cocktail from Roche). The sample
was homogenized with five and then two strokes with large and low-clearance
pestles, respectively, and the homogenate was centrifuged at 5,000 3 g for
20 min at 4C. The supernatant was complemented with 1% Na deoxycholate
and 1% Triton X-100 and then loaded onto a 12 ml sucrose gradient (20% to
50% sucrose in buffer A containing 100 mg/ml cycloheximide and 10mMDTT).
The gradients were centrifuged at 39,000 rpm for 2 hr at 4C in an SW40Ti rotor
(with maximum acceleration and no deceleration), and 1 ml fractions were
collected with continuous monitoring of UV254nm absorbance. RNA was ex-
tracted using TRIzol LS reagent (Invitrogen) and reverse transcribed in dupli-
cate as described above. An equal amount of in vitro-transcribed Firefly
luciferase RNA was added to each fraction prior RT and used as an internal
standard to correct for potential variation in RT efficiency.
59Fe Absorption
59Fe whole-body retention was measured 2 weeks after the fifth dose of TMX
for IRP ablation. Mice received a single oral dose of 59Fe by gavage of 10 mM
FeSO4 in 10 mM HCl supplemented with 4 mCi
59FeCl3 (NEZ 37; Perkin Elmer,
Mechelen, Germany) in a volume of 50 ml. The applied 59Fe dose was deter-
mined immediately after gavage using a whole-body counter (100% value,
Typ AW3; MAB Solutions, Dettenheim, Germany). The animals were sacrificed
6 hr or 7 days later, respectively. The entire intestine was removed and 59Fe
retention in the carcass was determined using a whole-body counter and ex-
pressed as percentage of the initially received 59Fe dose. 59Fe levels were
determined again after removal of the head, skin, and paws to test for potential
contamination after regurgitation of the 59Fe solution. No contamination of the
fur, paws, or scull was detected. To determine mucosal 59Fe levels, the small
intestine was carefully flushed, opened longitudinally, and rinsed extensively
with 10 mM FeSO4 in 10 mM HCl. Duodenal segments were placed (72 hr,
80C) in a drying chamber (Memmeret, Schwabach, Germany) and weighed
(analytic balance, d = 0.001 g; Denver Instruments, Go¨ttingen, Germany)
and radioactivity was determined using the AW3 gamma counter.
Total Nonheme Iron Levels
Duodenal, liver, and spleen tissues were dried and their nonheme iron content
wasmeasured using the bathophenanthrolinemethod as described previously
(Galy et al., 2005b).
Microscopy Analysis
Duodenal samples were fixed in formaldehyde and embedded in paraffin.
Perl’s staining images were acquired using the Nis Elements software and
an Eclipse Ni-E microscope equipped with a DS-Ri1 camera (Nikon GmbH,
Du¨sseldorf, Germany).
Statistical Analyses
Data are presented as mean ±SEM unless otherwise specified. Statistical
analyses were performed using Prism software (GraphPad Software, La Jolla,
CA, USA). Differences between two mean values were evaluated by the two-
tailed Student’s t test. Multiple groups were compared by one-way ANOVA
with Bonferroni post hoc analysis. A p value < 0.05 was considered significant.Cell Reports 3, 844–857, March 28, 2013 ª2013 The Authors 855
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